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Abstract
Psychological therapy today plays a key role in UK public mental health. In large part, this has 
been through the development of the (specifically English) Improving Access to Psychological 
Therapies (IAPT) programme. Through IAPT, millions of citizens have encountered interventions 
such as cognitive behaviour therapy, largely for the treatment of depression and anxiety. This 
article interrogates how this national response to problems of mental ill-health – and the 
problematization itself – was developed, accounted for, and sustained. By imbricating economic 
expertise with accounts of mental ill-health and mechanisms of treatment, IAPT has revivified 
psychological framings of pathology and therapy. However, it has done so in ways that are 
more familiar within biomedical contexts (e.g. through recourse to randomized controlled 
trial studies). Today, the initiative is a principal player in relation to which other services are 
increasingly developed. Indeed, in many respects IAPT has transformed from content to context 
within UK public mental health (in a process of what I term ‘contextification’). By documenting 
these developments, this paper contributes to re-centring questions about the place and role of 
psychology in contemporary healthcare. Doing so helps to complicate assumptions about the 
dominance of linear forms of (de)biomedicalization in health-systems.
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At the turn of the century, an adult in England who felt very down, lacking in hope and 
unable to enjoy everyday pleasures might have made an appointment with their General 
(Medical) Practitioner (GP). The GP would then, perhaps, have decided that their patient 
was suffering from depression, with a prescription for a pharmaceutical such as a selec-
tive serotonin reuptake inhibitor (SSRI) being a likely outcome. Today, there is a reason-
able chance that some kind of talking therapy would be recommended. In fact, a GP 
appointment is not always necessary at all: The potential patient may call a local National 
Health Services (NHS) therapy service, and refer themselves directly. Such services are 
likely to be badged as part of, or to have evolved from, something called the Improving 
Access to Psychological Therapies initiative (IAPT).1 This much-lauded public health 
programme has had many millions of pounds invested in it, with the objective of making 
treatment for mental illness more accessible (Department of Health, 2012).
The beginnings of IAPT are largely associated with the campaigning of (among oth-
ers) London-based clinical psychologist David Clark and health economist Lord Richard 
Layard. Through IAPT, the number of clinicians delivering therapy has proliferated and 
ideas about the salience of the psychological within the NHS have been reshaped. During 
the early days of IAPT, therapists targeted men and women of working-age and focused 
on depression and anxiety, employing psychological interventions to treat those condi-
tions. IAPT later began to include older adults (Ghosh, 2009), and since 2011 children 
and adolescents have been part of its remit (Fonagy and Clark, 2015). Services have 
further extended into the terrain of ‘severe and enduring mental illness’ (Jolley et al., 
2015).2 With this significant expansion, IAPT has gained substantial media coverage in 
the UK and subsequently abroad; for instance, one New York Times article described it as 
‘the world’s most ambitious effort to treat depression, anxiety and other common mental 
illnesses’ (Carey, 2017). An editorial in the journal Nature (2012) asserted that IAPT 
‘represents a world-beating standard thanks to the scale of its implementation and the 
validation of its treatments’ (p. 473). Such comments have acted to stimulate, and have 
been stimulated by, significant international clinical and policy attention to and mimesis 
of the initiative.
Here, I examine the instantiation, operations and ramifications of IAPT. I draw on 
interviews with key professional and policy actors working in organizations that shape 
the wider field of psychological care, alongside interviews and conversations with doz-
ens of NHS clinicians (especially psychologists). My dataset also includes an array of 
English, UK, and international policy papers, journal articles, clinical guidelines and 
charity campaign materials (from 2011 onwards). These were assembled and interro-
gated in order to better understand the timeline of the development and reception of the 
IAPT initiative, and the repertories of accountability through which it has been both 
celebrated and critiqued.3
This article focuses on some of the movements in healthcare that the IAPT initiative 
reflected, helped to stabilize, and further propelled. I argue that the programme has 
helped to revivify psychological framings of pathology and therapy, and consolidated the 
role of economic expertise in adjudicating the nature and treatment of mental ill-health. 
However, it has done so in ways that are more familiar within biomedical contexts (e.g. 
through recourse to randomized controlled trial (RCTs) studies). Consequently, it has 
enjoined wider shifts in the landscape of UK mental healthcare. I suggest that IAPT has 
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changed from being one ostensibly novel component of this terrain, to become an ele-
ment around which other services are constituted. More generally, this paper aims to 
augment the attention of Science and Technology Studies (STS) to psychological science 
and practice. Such a focus invites questions about the extent to which we can accept 
biomedicalization as a de facto process underlying healthcare systems in high-income 
countries.
Minds, money and biomedicine
As Petit (2015) has argued in this journal, psychology has ‘occupied a fairly marginal 
place within the history of science and STS’ (p. 154). Work does of course exist, scat-
tered across different historiographical and STS traditions.4 In particular, the history of 
psychoanalysis has long been a thriving field (e.g. Hale, 1971; Sulloway, 1992; Turkle, 
1978); further, there is also new interest in the historical dimensions of more recent 
therapeutics (Marks, 2017) like Applied Behaviour Analysis (ABA; Kirkham, 2017) and 
Cognitive Behavioural Therapy (CBT; Marks, 2012).5 Still, there remains a need for STS 
scholars to produce ‘greater specificity about psychology’s impact’ (Petit, 2015: 147; see 
also Stark, 2018).
This article represents one of many possible responses to Petit’s enjoinment, through 
the analysis of the origins (and impacts) of IAPT. The attention to IAPT that this article 
provides is, I think, particularly timely with regards to the possibility it offers for reflect-
ing on key issues often considered to underpin contemporary healthcare in a range of 
nations. These are, first, the role of the economic matters in shaping care and treatment, 
and, second, the process of biomedicalization (Clarke et al., 2010).
In the case of the former, economic concerns shape healthcare innovation, design and 
delivery (Conrad, 2005). Economic expertise itself has also come to be increasingly 
advocated for and ultimately leveraged within health systems (e.g. in the UK). This has 
involved the reformulation of administrative challenges and questions for managers and 
clinicians in economic terms (Ashmore et al., 1989; Mulkay et al., 1987). Accordingly, 
the assessments of health economists can both expand and limit the availability and 
accessibility of different treatments (e.g. Moreira, 2011). Health economic analyses of 
ill-health and treatment options now have a kind of ‘evidentiary charisma’ (in the terms 
of Kelly, 2018) within political frameworks that orient policy towards enjoining various 
kinds of financial accountability and reify this as a public and moral good. In this paper, 
I show how economistic approaches to accounting for the efficacy of psychological ther-
apy significantly shaped understandings of its public health and clinical value, and the 
technicalities of its application. Through such conceptions, economic knowledge became 
imbricated within the ontologies of the IAPT programme and the psychopathologies it 
sought to address.
Biomedicalization (Clarke et al., 2003, 2010) can be summarized as the processes by 
which health and illness come to be defined by and intervened in through explicitly bio-
medical praxis. Within the framework of biomedicalization, a key conceptual emphasis 
is the embroilment of medicine with technoscientific ideas and innovation (cf. the notion 
of medicalization). Influential within STS, sociology, anthropology, and beyond, Clarke 
et al. grounded their initial empirical work and theorization primarily within the US. 
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Subsequent scholarship has deployed the concept through case-studies in other nations, 
including the UK (e.g. Carter et al., 2018; Norman et al., 2016; Young et al., 2016). Most 
studies of biomedicalization have examined its emergence and implications; fewer have 
considered the ‘countertrends and complications’ that Clarke et al. (2010: 15) argued are 
important to note. The rise of IAPT neither straightforwardly supports nor refutes theo-
ries of biomedicalization; instead, I suggest that it signals there is more to contemporary 
healthcare.
Some of the shifts this paper documents are powered through practices of problema-
tization. By this I mean the dynamic and intertwined processes of defining and tackling 
‘problems’ (Callon, 1986). In what follows, I demonstrate the particularly economic 
problematization undergirding IAPT. Following its success, the initiative has been (held 
to be) a model for other mental health services, and helped to legitimize bodies that have 
the capacity to shape healthcare (e.g. the National Institute for Health and Care 
Excellence, NICE). The instantiation of IAPT has thus informed wider policy and prac-
tice in the UK and beyond. My thinking on this draws on the work of MacKenzie and 
Pardo-Guerra (2014), in which they narrate ‘the story of Island – a new electronic plat-
form for the trading of shares’ (p. 153). MacKenzie and Pardo-Guerra (2014) showed 
how what ‘was originally a ‘micro’ development on the fringes of US markets’ came to 
have considerable import such that ‘within little more than a decade key features of 
Island became close to compulsory’ (p. 153). As MacKenzie (2015) has elsewhere 
described, Island thus shifted from being ‘content to context’. Here, I call such a process 
‘contextification’, and indicate how IAPT has been contextified within the UK. Today, it 
is a significant entity within mental healthcare, producing new standards against which 
other ventures can be held to account.
Problematizing access
As noted above, IAPT can be largely traced to the actions of two individuals: David 
Clark and Richard Layard. Currently a professor at the University of Oxford (previously 
King’s College, London), Clark is prominent for his research around anxiety disorders 
and as a key innovator of a psychological treatment called cognitive behavioural therapy 
(CBT). This is aimed at changing how people think and feel about situations and indi-
viduals that, for instance, make them feel depressed or anxious. Layard was a professor 
at the London School of Economics and Political Science (LSE), and is a very influential 
economist. He remains a member of the Labour Party in the elite UK House of Lords, 
and has played major policy roles around mental health and wellbeing. First meeting at 
a British Academy event in 2003, Clark and Layard came to work together to try and 
move access to therapy further up the policy agenda (Evans, 2013a, 2013b; Layard and 
Clark, 2014). To do so, it seems that they actively sought to expand their own influence 
regarding how issues of access and therapy should be understood and addressed. Their 
research and campaigning found favour within the Department of Health and at Downing 
Street, helping to impel reconfigurations of the matrix of clinicians, services, guidelines, 
treatment sites, and more that comprise English mental healthcare. Ultimately, they 
played vital parts in orchestrating the development and roll-out of IAPT.
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The campaigning of Layard and Clark did not, of course, emerge de novo. In the 
1990s and during the early 2000s, many patients and clinicians were troubled by ever 
more testimonies that people experiencing mental ill-health were not receiving the 
care they needed (or that waiting times were shockingly long). Policymakers took this 
issue to be important, with admission to services noted in (for instance) a major NHS 
policy document, ‘A National Service Framework for Mental Health’ (Department of 
Health, 1999). This also stated a need to expand the numbers of professionals compe-
tent to deliver mental health interventions. Wider concerns were furthermore emerg-
ing about the economic ‘costs of mental illness’ (Sainsbury Centre for Mental Health, 
2003: 1). Layard proved adept at steadily entwining these discourses of access and 
economy, focusing on depression specifically, and ultimately delimiting a straightfor-
ward framing of the (economic) problem(s) of access. In the early 2000s, he was an 
active publisher across a range of discursive spheres and his widely reviewed trade 
book, Happiness: Lessons from a New Science (Layard, 2005b), argued that depres-
sion was a social problem that could be addressed through psychological therapy. 
Following the publication of Happiness, Layard also wrote various clinically oriented 
articles (e.g. Layard, 2006a) and was a regulator discussant with journalists and poli-
cymakers, talking on related issues. Through such activities, Layard worked to at 
once characterize the nature of the problem of access, and to articulate its solution (cf. 
Callon, 1986: 196).
Layard’s messaging generated policy traction. For example, in January 2005, he 
was invited to present a report to the Prime Minister’s Strategy Unit, in a seminar at 
which Clark was also present (Evans, 2013b), on ‘Mental Health: Britain’s Biggest 
Social Problem?’ (Layard, 2005a).6 This document claimed that mental illness ‘imposes 
heavy costs on the economy’, asserting (in bold typeface): ‘There are now more men-
tally ill people drawing incapacity benefits than there are unemployed people on 
Jobseeker’s Allowance’ (Layard, 2005a: 1). An apt response, Layard argued (like the 
Department of Health before him), was a massive expansion of the mental health 
workforce.
Senior Labour figures seemed to have been receptive to Layard’s arguments: 
Following his presentation, The Labour Party (2005) Manifesto committed to improve 
mental health through ‘behavioural [i.e. psychological] as well as drug therapies’ (p. 65). 
The phrasing of the manifesto promise presented psychological services as a kind of 
addition to the (pharmaco)therapeutic status quo. It thus underscored neurobiology as a 
key aspect of the UK mental health landscape (see Pilgrim and Rogers, 2005; Rose, 
2007). Yet, the commitment also reflected increasingly outspoken voices (such as 
Layard’s) in support of proliferating specifically psychological therapy. As we will see, 
the Labour Party pledge ultimately materialized as the IAPT initiative.
Layard’s 2005 paper subsequently evolved into ‘The Depression Report’ (Centre for 
Economic Performance, 2006). Released on 19 June 2006, it was also widely termed ‘the 
Layard Report’, indicating the importance ascribed to Layard in developing IAPT. 
Though most associated with him, the report advertised its authority through a list of 
impressive-sounding signatories from mental health research and practice, including 
Clark. It further demonstrated epistemic accountability through its digestible number of 
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endnotes linking the claims it made to relevant academic literature. Immediately prior to 
publication, Layard promoted ‘The Depression Report’ in The Guardian newspaper 
(Layard, 2006b), with the online edition linking to the LSE website where the report 
could be downloaded. It was further heralded on its release date in The Observer (the 
Sunday version of The Guardian), which later circulated a hardcopy.7 Such widespread 
dissemination enabled ‘The Depression Report’ to act as a rhetorical and collectivizing 
device for articulating a particular problematization of access to therapy, and expanding 
discussion on depression more generally (cf. Callon, 1986).
The overall message of ‘The Depression Report’ was straightforward: Depression 
costs the economy, it should be treated, and treatment was affordable. Economics was a 
key apparatus through which its normative and clinical claims were assembled. Readers 
were, for instance, told that ‘the total loss of output due to depression and chronic anxiety 
is some £12 billion a year – one per cent of our total national income’ (Centre for 
Economic Performance, 2006: 5; bolded for emphasis in the original). The word ‘cost’ 
appeared 24 times in the main text of the 14-page report, including in a section subtitle 
that added the prefix ‘cost-effective’ to the word ‘therapies’. Pound signs were scattered 
throughout the report, and – like Layard’s 2005 paper – the number of people diagnosed 
with mental illness receiving state benefits appeared on the first page. Even the subtitle 
of the report – ‘A New Deal for Depression and Anxiety Disorders’ – gestured towards 
the economy, implicitly reminding readers of the culturally resonant 1930s US ‘New 
Deal’ economic development program. Altogether, it constructed a vision of a society 
full of despondent individuals whose despair impacted not only themselves, but also (the 
wallets of) the wider citizenry.
More than any other text of the time, ‘The Depression Report’ intertwined mental 
health and the economy within public discourse, relating expertise associated with the 
latter as an essential feature of (evaluating) attempts to understand and manage the for-
mer. Such an economistic framing attracted criticism from many mental health profes-
sionals at the clinical coalface (evident across a range of blogs, newsletters, and journals). 
Nevertheless, it also garnered support for the therapeutic options it outlined: i.e. psycho-
logical therapy. As noted, drug treatments for and a neurobiological understanding of 
depression were prominent within broader popular discourse at the time (Rose, 2007), 
even if these were never hegemonic (Pickersgill, 2014). ‘The Depression Report’ instead 
urged NHS to adopt psychological therapies for redressing the economic, social, and 
personal costs of depression. It stated that ‘hundreds of clinical trials’ had helped to show 
that ‘therapy is as effective as drugs in the short-run’, and that psychological therapy ‘has 
more long-lasting effects than drugs’ (Centre for Economic Performance, 2006: 6, bolded 
in original). This promotion was ostensibly a consequence of economic calculation 
rather than overt ontological partisanship over what depression ‘really’ was: overall, 
talking therapy was presented as the most (cost-)effective solution to a pressing social 
problem.
In my fieldwork, psychologists and others often mentioned Layard as significant in 
helping to shift the mental healthcare landscape, and IAPT itself was referred to as, for 
instance, the ‘Layard initiative’ (respondent 2). Nevertheless, important as he was, 
Layard by no means acted alone. As illustrated above, his arguments took considerable 
cues from policy reports and charitable briefings. Aside from David Clark, Layard also 
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worked with colleagues at the LSE (e.g. Layard et al., 2007), and the emphasis on psy-
chological therapy within his campaign put him in dialogue with wider advocacy that 
operated as ‘a, kind of, pincer movement’ (respondent 6) to direct change in policy. In 
this regard, a range of largely London-based actors and networks were producing docu-
ments and statements about access to talking therapies. For instance, one third-sector 
report, ‘We Need to Talk’ (Bird, 2006), served as a de facto companion text to ‘The 
Depression Report’; it emphasized the effectiveness of psychological treatment, the long 
waiting times for accessing it, and the economic costs of lost work.8 A loose association 
of major figures in UK mental health research, policy, and practice also formed under the 
banner of the ‘New Savoy Partnership’.9 In 2007, they released the ‘New Savoy 
Declaration’; this called ‘on the NHS to offer appropriate psychological therapies free at 
the point of delivery to all people who need them’ (New Savoy Partnership, 2007). 
Hence, the widely circulated ‘Depression Report’ served to publicize the goals and fur-
ther the momentum of a diffuse and diverse undertaking that was already beginning to 
gain interest and investment within Westminster.
From 2003 to 2006, an intense campaign from elite metropolitan academics and clini-
cians, and well-known organizations and charities, sought to move mental health higher 
up the policy agenda. This also related to, and was reciprocally informed by, wider gov-
ernmental strategy and commitments to work and (psychological) wellbeing (Edwards 
and Imrie, 2008; HM Government, 2005; Rick et al., 2010). These stakeholders – among 
whom Layard and Clark were significant – helped to set and propel a programme for 
expanding access to psychological care. In doing so, they contributed, via an especially 
economic problematization, to the reworking of the mental health landscape from which 
IAPT emerged. At an early point in the campaigning, this landscape – configured through 
extant policy and clinical praxis – was one within which a thing called ‘depression’ could 
be straightforwardly delineated and operated upon by certain techniques, with those suf-
fering from it understood to be disadvantaged by public health infrastructures that lim-
ited access to treatment. The activities of Layard and others helped to reshape it such that 
both economic and psychological rationalities became vital features. Depression was 
reified as something that should be treated primarily through psychological therapy, and 
which could be accounted for in terms of its economic costs (with calculations of cost 
also justifying psychological rather than pharmaceutical interventions). Accordingly, 
depression was constructed as an object not just of concern to individuals categorized as 
having the disorder, but to the State and the body politic more broadly.
Remaking infrastructures and expertise
Following their commitment to improve mental health services (The Labour Party, 2005: 
65), in 2006 the re-elected Labour government granted over £2 million for trialling a new 
programme for enhancing access to therapy within primary care: IAPT (Department of 
Health, 2012). A few weeks prior to the dissemination of ‘The Depression Report’ 
through The Observer, two IAPT pilots were launched, in the city of Doncaster and in 
Newham, East London.10 These were rapidly subject to various kinds of elaboration and 
attention. A business case was advanced in November 2006 to expand IAPT nationally, 
with funding confirmed in 2007 (Rick et al., 2010). By 2008, the vision of enhancing 
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access to therapy outlined in ‘The Depression Report’ (and elsewhere) was made 
manifest.
Though ostensibly a bounded initiative dedicated to improving primary mental health 
care in England, IAPT became – in the words of one Scottish mental health policy actor 
(respondent 1) – a ‘hugely influential’ (emphasis in original) programme. This has been 
partly in light of the ‘fundamental economic argument’ that ‘Richard Layard and Dave 
Clark put forward’, and how IAPT ‘is rolling out’ and ‘the way it’s been done’. In this 
section and the next, I want to sketch out the contours of IAPT, and examine how its 
novelty and legitimacy were accounted for in order to maximize the material and sym-
bolic investment that generated such influence. In setting out ‘the way it’s been done’, I 
will demonstrate how the ‘economic argument’ justifying the initiative has become 
tightly imbricated with the practices of care and accountability performed through the 
programme.
In my interviews and documentary analysis, five key features of IAPT were regularly 
foregrounded: the introduction of ‘self-referral’, the proliferation of therapists, the devel-
opment of ‘stepped care’, a focus on evidence-based therapies, and the measurement of 
outcomes. To begin with, I interrogate the first three of these significant characteristics 
of IAPT; these comprise the infrastructural innovations of the initiative most directly 
geared towards its stated aims of making therapy ‘accessible’. In the next section, I 
attend to the design and nature of the therapeutic provision of IAPT, and how this was 
rendered (ac)countable. The use of evidence-based therapies and outcome measures 
were central to the construction, management and maintenance of (what has been often 
regarded as) the success of IAPT. Hence, these features played a somewhat different, 
though seemingly vital, role in proliferating psychological care. As we will see, they also 
responded to – and had ramifications for – wider UK mental healthcare.
In IAPT, people can generally contact services directly to request an appointment. 
This process of ‘self-referral’ was regarded as significant by many of the policy and 
clinical actors I encountered during my fieldwork. Still uncommon in other mental health 
settings, it was deemed to avoid the ‘barriers’ to accessing therapy that GPs were (and 
still are) often understood to impose. Self-referral was widely perceived as a ‘radical 
shift’ (Brown et al., 2010: 365) that would help many more individuals who understood 
themselves to be depressed and in need of treatment. So important was it to the leaders 
of IAPT that the number of patients self-referring served as a key performance indicator 
for services within the initiative (Department of Health, 2011). Hence, self-referral rep-
resented a means by which IAPT could simultaneously contribute to addressing its core 
problematic (i.e. enhancing access) and account for the extent to which this was achieved. 
In problematizing referral and offering a targeted solution, the architects of IAPT were 
further able to present their initiative to policy and clinical communities as a logical, 
rational endeavour with respect to the managerial and therapeutic mores of UK health-
care. Subsequently, the apparent success of the self-referral processes of IAPT has been 
argued to support the need for this mechanism in other UK mental health services (e.g. 
Brown et al., 2010).
Alongside such efforts to make care more directly accessible, the IAPT initiative 
greatly increased the number of health professionals able to deliver treatment, through 
the positioning of very many clinicians within a number of new services. A considerable 
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proportion of the IAPT investment was spent on training several thousand cognitive 
behaviour therapists and new ‘psychological wellbeing practitioners’ (PWPs) (Clark, 
2011: 318). Today, they work across more than 100 IAPT services, commonly delivering 
highly prescriptive forms of CBT – a so-called ‘manualized’ therapy. These profession-
als were initially tasked with treating individuals diagnosed with ‘mild to moderate’ 
anxiety and/or depression for a discrete (6-10) number of therapeutic encounters. Therapy 
was not regarded as requiring the expertise of doctorate-holding clinical psychologists, 
who were also more highly paid and demanded more autonomy. Hence, the training and 
employment of less expensive cognitive behaviour therapists and PWPs, who worked 
within closely defined clinical parameters, further optimized IAPTs economic 
outcomes.
The clinical foci and professional demographics of the IAPT workforce are thus 
indicative of how the economic rationalities inherent in the conception of the initiative 
continued to be emphasized within programme delivery. IAPT – along with other NHS 
policy that enjoined so-called ‘New Ways of Working’ (e.g. Care Services Improvement 
Partnership/National Institute for Mental Health in England (CSIP/NIMHE), 2007) – 
also affected figurations of therapeutic expertise and therapy. In IAPT and elsewhere, 
psychologists came to be decreasingly viewed as the primary professionals who should 
deliver psychological therapy. Rather, other psychologically-trained clinicians were able 
to claim sufficient expertise, assuming therapeutic protocols were closely followed. This 
shift helped to shape meanings of therapy beyond that delivered through IAPT. Gradually, 
therapy has become progressively characterized in a range of settings as a kind of pre-
packaged tool that professionals, sometimes with relatively limited credentialed psycho-
logical expertise, can be trained to use in specific, pre-determined ways.
Unsurprisingly, many working in clinical psychology have lamented this widespread 
recasting of expertise and therapy. One senior psychologist told me how IAPT had 
‘caused a lot of disquiet’ (respondent 2) – something evident during my conversations 
with mental health professionals – with, for instance, the ‘deskilling’ (respondent 9) of 
psychological services registering as a concern. In terms of the therapeutic orientation of 
IAPT, a policy advisor to the initiative (respondent 7) described how he had been 
‘besieged’ by criticisms about its focus on CBT. With the rising prominence of IAPT and 
restrictions in wider healthcare funding, clinical psychologists increasingly display their 
clinical and economic worth (cf. PWPs, for example) by underscoring their skill in disas-
sembling manualized therapies and recombining them on a patient-by-patient basis. This 
is in relation to a specific clinical formulation of a presenting problem and the psychoso-
cial milieu inhabited by the patient. Such collective transformations in psychological 
knowledge and action are not reducible to IAPT; nevertheless, they have been propelled 
and authorized through the initiative, given its scale and the attention its architects 
attracted and demanded.
Connected to shifts in therapists and therapy were new institutional logics regarding 
the sorting out of populations suitable for therapy. Since the inception of IAPT, the care 
apportioned through its services has been undertaken in a self-consciously ration(aliz)ed 
fashion that is ubiquitously described as ‘stepped’. For example, a ‘low intensity’ CBT 
intervention (such as guided self-help) can be initially provided to patients, who might 
then be ‘stepped up’ to a more ‘high intensity’ treatment in the absence of recovery. 
10 Social Studies of Science 00(0)
Levels of care relate to different kinds of intervention administered by professionals with 
differing (kinds and degrees of) expertise. Seen as sitting ‘at the heart of the IAPT clini-
cal model’ (Gyani et al., 2013: 605), stepped care is constituted through a conception of 
what we might term ‘therapeutic wastage’. It is deployed to prevent the loss of expertise, 
time, and, consequently, money to the treatment of mild depression, when these could be 
more swiftly applied and better spent (and accounted for) to and on other individuals 
understood to be experiencing more severe forms of distress.
IAPT did not, in fact, introduce the notion of stepped-care (see e.g. Bower and 
Gilbody, 2005). However, its use has proliferated through the salience of this model in 
what has been a very well-resourced and highly promoted programme. Many of my 
interlocutors worked in services that are today structured through a kind of stepped-
care approach, with implications for managing patient waiting lists. This form of care 
generally relates closely to values of cost-effectiveness. While these have long been 
part of British clinical life (e.g. Department of Health, 1999), their presence has been 
particularly apparent since the austerity policies enacted in the wake of the 2008 finan-
cial crisis, and almost every psychologist with whom I spoke expressed anxiety regard-
ing service capacity vis-à-vis post-2008 budget restrictions. It was around this time 
that the infrastructures of IAPT were being touted as therapeutically and economically 
effective by key clinical proponents, such as Clark (e.g. Clark et al., 2009). Stepped-
care, then, represented an answer to more than one problem. Through it, economic 
practices of accounting and clinical practices of accountability could (co-)produce the 
same ends; i.e. in principle, more people could be seen for therapy at ostensibly lower 
costs. Stepped-care systems also resonate with a certain notion of mental ill-health, 
one in which severity is not merely an abstract dimension of distress, but is more or 
less categorical and quantifiable (e.g. ‘mild to moderate’, and ‘severe and enduring’ 
depression). Hence, stepped-care represents a further example of how, through IAPT, 
economic understandings of care provision have become increasingly enmeshed within 
clinical considerations.
Knowing what works
In my interviews and conversations with policy actors, IAPT was commonly presented 
as a rational approach for intervening in a concrete economic, social, and clinical prob-
lem. Increasing access to psychological therapies was ‘the sensible thing to do’, as one 
policy advisor put it, not least because it would generate ‘a cross-ministry saving’ 
(respondent 10). Relating to such economic rationalism, the stated goal of IAPT was ‘to 
greatly increase the availability of NICE recommended psychological treatment’ (Clark, 
2011: 318; emphasis added) – not therapy in general. NICE (the National Institute for 
Health and Care Excellence) is a public body that has a ‘consistent’ (respondent 12) 
process for the production of NHS clinical guidelines through expert Guideline 
Development Groups; within these, RCT evidence and assessments of cost effectiveness 
are salient (Moreira, 2011).11 Key to how the organization presents and performs account-
able action are the visibility of its processes of knowledge production, and the manage-
rial and clinical applicability, scientific veracity, and public and political palatability of 
its recommendations.
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By framing the operations of IAPT as mandated by NICE, its advocates have been 
enabled and emboldened to make claims that the initiative is clinically and epistemically 
accountable. Through these accountabilities, the programme can then be constructed as 
economically and politically durable, with ‘an authority that goes beyond the authority 
of any particular professional group’ (respondent 10). By following NICE, IAPT could 
deliver ‘treatments that we know work’ (respondent 4; emphasis in original). Another 
interviewee reflected that although ‘not everyone welcomes or accepts’ NICE, it ‘is the 
only show in town, at least at this stage, to keep the investment flowing’ (respondent 3; 
emphasis in original). Indeed, Layard and Clark (2014) have asserted that ‘the expansion 
of psychological therapy would never have happened at all without NICE’ (p. 206). CBT 
was prominent within the 2004 (and 2009) NICE guidelines for depression, and the 
architects of IAPT elected to emphasize this modality in their initiative. By ascribing 
dominance and import to NICE, this decision-making can be reframed as no choice at 
all: ‘[I]n terms of a large scale programme we are almost obliged to go from where the 
evidence sits’ (respondent 3; emphasis in original).
Nevertheless, NICE is not an uncontested organization. During my fieldwork, I regu-
larly encountered dissatisfaction about it from psychologists and other clinicians. Such 
discontent related to how NICE produced knowledge and subsequently guidelines, with – 
as one senior figure associated with the organization noted – ‘a number of people’ regard-
ing it as being ‘too focused on CBT, to the exclusion of other psychological therapies’ 
(respondent 12). Concerns have been, and continue to be, advanced within peer-reviewed 
and more informal literatures, with frustration about the calculative style of NICE com-
monly articulated. One critical journal article nicely summarizes some of the concerns in 
its title: ‘The NICE guidelines are misleading, unscientific, and potentially impede good 
psychological care and help’ (Mollon, 2009). These debates are part of a wider critique of 
NICE (see Abraham, 2010; Moreira, 2011; Syrett, 2003), while developing a certain char-
acter through their refraction across the mental health professions. This relates especially 
to the occlusion of non-RCT treatment studies by the Guideline Development Groups, 
longstanding debates about the role diagnostic constructs (e.g. ‘major depression’) should 
play within psychology, and the related use of manualized therapeutic approaches targeting 
categorical pathologies (e.g. CBT) (Pilgrim, 2011). Despite these critiques, logics of quan-
tification of the kind NICE is underpinned by and contributes to reifying are increasingly 
threaded through UK mental health praxis.
‘Evidence-based medicine’ (EBM) has long had traction within the UK (Armstrong, 
2007); likewise, health economics has shaped healthcare delivery for decades (Mulkay 
et al., 1987). Still, these trends towards EBM and the deployment of economic expertise 
have certainly intensified. Early in the twenty-first century, NICE – then a young organi-
zation – operated at some distance from the everyday concerns of clinicians at the 
coalface of practice (cf. Hedgecoe, 2004). The first depression guidelines were only 
produced in 2004; prior to this, just three guidelines in mental health were available, on 
schizophrenia, eating disorders, and self-harm. In 2004, key players within NICE felt the 
need to write an article for the Royal College of Psychiatrist’s Psychiatric Bulletin intro-
ducing their organization and its activities (Kendall et al., 2004). Suffice it to say, these 
days NICE needs no introduction to clinicians whose practice is marked deeply by its 
recommendations.
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The import of NICE in mental health has thus grown alongside the expansion of IAPT 
itself, with both increasingly interacting with one another. For example, Clark chaired 
the 2013 Guideline Development Group studying social anxiety disorder, the recommen-
dations of which also emphasised a cognitive model of this construct (and subsequent 
treatment regimens) Clark developed with Adrien Wells (Clark and Wells, 1995; NICE, 
2013: 10). Further, the perceived successes and practices of IAPT informed the evidence 
examined and generated by more recent NICE Guideline Development Groups (e.g. 
BPS/RCPsych, 2011: 80; NICE, 2011). Fifteen years since Kendall and colleagues 
sought to raise awareness of NICE, its dominance today inspires voluble criticism 
through which professionals reassert their authority to define subjective distress and 
therapeutic expertise in the face of the organization doing so for them, and following the 
expansion and trumpeting of new kinds of practice via IAPT.
With the endorsement and encouragement of NICE, CBT has come to be widely pro-
moted and operationalized within British mental health services. During my fieldwork I 
asked dozens of clinical psychologists about their therapeutic practice; they almost 
always replied that, at minimum, they drew upon CBT approaches. IAPT itself has regu-
larly been taken to task for its perceived (over-)reliance on this modality. One key criti-
cism I encountered related to the notion that CBT has a good evidence base, which was 
framed as explaining its promotion through NICE guidelines. Critics argued that trials 
for therapies that already indicated effectiveness in some populations were more likely 
to be sponsored for further research than untested modalities. Accordingly, further evi-
dence would be generated, with which NICE’s Guideline Development Groups might 
engage. In effect, knowledge about the effectiveness of CBT was presented as partly an 
artefact of a positive feedback loop, accelerated by the readiness to which manualized 
forms of CBT could be subjected to evaluation through RCTs. Again, such critiques 
illustrate a shifting landscape in which (particular kinds of) ‘evidence’ has come to be 
central to the constitution of practice; hence, the nature of that evidence is reflexively 
subject to uncertainty and debate.
In interviews with policymakers, policy advisers, and key clinicians, I sometimes 
invited reflections on the criticisms that IAPT, CBT, and NICE had attracted. These par-
ticipants largely responded by presenting the widespread instantiation of CBT, the import 
of NICE, and the necessity of IAPT operationalizing NICE guidelines as rational and 
reasoned. One asserted: ‘if you think you should be trying to invest in evidence-based 
things then you need to be pushing the things that have evidence’ (respondent 10). A 
senior member of the British Psychological Society reflected: ‘if one draws on the evi-
dence base … what else could you do?’ (respondent 2). Concerns about CBT were 
reframed by a senior policy actor as an indication that those working in other therapeutic 
traditions needed ‘to generate the evidence’ (respondent 3; emphasis in original) for their 
interventions in ways that NICE would recognise as legitimate. A more diverse array of 
therapies might then be included in future recommendations, and thus within IAPT. My 
interlocutor argued that this perspective was ‘not unreasonable, particularly in these 
straitened circumstances’. Even as evidence around CBT is decoupled from the social, 
technical, and economic contexts of its generation in order to justify its deployment, the 
reality that evidence needs to be actively made is therefore used as a means to critique 
the critics. This kind of shifting register was, I found, common in defences of IAPT: 
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criticized on epistemic, economic, or humanitarian grounds, responses could readily be 
assembled from one of the other dimensions of the programme that reconstructed chal-
lenges as unreasonable or ill-informed.
(Acc)Counting (for) success
Clark and Layard, as well as other IAPT leaders, have articulated the import and novelty 
of the initiative through health economic forecasts, the synthesis of clinical guidelines, 
invocations of human need, and eventual evaluation via the monitoring of clinical and 
socio-economic outcomes. Healthcare evaluation represents a key means of establishing 
intervention efficacy and demonstrating political and economic accountability (Broer 
et al., 2017), and has been leveraged extensively within IAPT. For instance, during the 
programme rollout various projects were developed to adjudicate its success, including 
an evaluation led by Clark and colleagues (2008) (see also Clark et al., 2009).12 
Information-collection, codified within the IAPT Data Standard (i.e. the list of data each 
IAPT service must collect), continues to enable the comparison and evaluation of indi-
vidual services. From April 2012, key data have been submitted monthly from IAPT 
service-providers to the UK Health & Social Care Information Centre (a non-departmen-
tal public body with the aim of aim of collecting comparative data to enhance quality and 
efficiency in healthcare). These data include demographic details about patients, the per-
centage of them deemed ‘recovered’, changes to their employment status, referral dates 
for calculating waiting times, and scores on inventories aimed at assessing (changes to) 
symptom severity for various conditions (e.g. the Patient Health Questionnaire, dis-
cussed below) (Clark et al., 2009; Department of Health, 2011: 19). Submitting data is 
itself a complicated process which involves considerable work in terms of the collection, 
anonymization, and authorization of the data, and decision-making with regards to who 
monitors and controls this. Though this mass collection of data, the effectiveness of 
IAPT is made (ac)countable.
Quantification can represent a solution to enduring issues of legitimacy and account-
ability (Porter, 1995), and patients in mental health settings have long been subject to 
diverse forms of calculation (Grob, 2009; Hirshbein, 2009). Within IAPT, though, the 
variety and consistency of data collected on patient characteristics and outcomes is com-
monly argued to be unprecedented. Communicated to practitioners through the ‘IAPT 
Data Handbook’, the rationales for this indicate the range of intertwining clinical, eco-
nomic, and political uses to which metrics are put:
1. Ensure equitable use of IAPT … by people experiencing depression and anxiety 
disorders from all communities within the local population, actively advancing 
equality …
2. Actively use data collection as part of the clinical process … to enhance patients’ 
and IAPT workers’ engagement in collaborative decision making and treatment 
plan reviews …
3. Provide objective case-load and outcomes data for supervisors to enable them to 
review the clinical work of IAPT workers …
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4. Provide IAPT workers with information that will help identify appropriate targets 
for intervention in the next therapy session …
5. Monitor the extent to which IAPT workers and services are providing evidence-
based treatments which are consistently applied in the manner recommended by 
NICE
6. Measure people’s experience and benefits from IAPT services
7. Assist commissioners and service providers in monitoring and improving the 
quality and cost effectiveness of their services for all communities
8. Build a robust data archive to inform evolving service improvement strategies …
9. (Department of Health, 2011: 10)
The production and harnessing of data for different but connected ends also serve to 
represent IAPT as a departure from more traditional means of undertaking and evaluat-
ing psychological treatment. One senior psychologist involved in the programme, for 
instance, told me how therapy delivered outside of IAPT could be ‘very ineffective and 
very poorly monitored’ (respondent 8). He claimed that this ‘shouldn’t really be allowed 
to carry on’, given the risk of ‘adverse effects’ from poor practice. Such morally laden 
talk about the potential negative effects of therapy – and hence the need to scrutinize the 
expertise and performance of professionals – is also articulated in formal IAPT policy 
(e.g. Department of Health, 2011: 13). Indeed, the very fact that measures are taken at all, 
notwithstanding the nature of the data itself or the uses to which it is put, can be rhetori-
cally deployed to perform the novelty and legitimacy of IAPT.
One means through which different forms of accountability come to be enmeshed in IAPT 
is through the employment of a tool called the Patient Health Questionnaire (PHQ-9), 
designed in the US in the late 1990s to screen for and assess depression (Kroenke et al., 
2001). It asks a series of questions about occurrences of depressed mood. Possible responses 
are: ‘not at all’, ‘several days’, ‘more than half the days’, and ‘nearly every day’. These cor-
respond to a number, with responses summed to produce an overall severity score: 0–5 is 
taken to indicate mild depression, 6–10 is moderate, 11–15 is moderately severe, and 16–20 
is severe. Following (self-)referral to IAPT, a patient is sent the PHQ-9 to complete. The score 
produced confirms a patient’s suitability for the service, provides the therapist a starting point 
for the first appointment, and acts as a benchmark for therapeutic progress. By rendering 
depression quantifiable, the PHQ-9 enables judgments of severity to be deemed reasonable 
and therapeutic gains to be recordable, rendering clinical action accountable (to patients and 
service leads). Accordingly, the PHQ-9 acts as a significant apparatus for consolidating 
understandings of ‘depression’ as a bounded and discrete disorder. It aligns well with CBT, 
which as Stark (2017) has observed, intertwines “an emphasis on numerical quantification 
with an ordinal schema of rationality, clarity and self-fashioning” (p. 70). By configuring pat-
ent subjectivities as calculable and surveillable, the PHQ-9 also enables the evaluation of the 
therapist, the service, and ultimately IAPT itself.
Layard and Clark (2014) have asserted that ‘outcome measurement is probably the 
most important single feature of IAPT’ and that it ‘is really the only ultimate guarantee 
of quality’ (p. 205). Presented as descriptive statements, such comments are normative 
proclamations. An interlocutor closely involved with the initiative told me that one rea-
son why IAPT was ‘successful’ was ‘because from the start’ it was decided ‘you have to 
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actually demonstrate that what you do is worthwhile’. This meant ‘that we just had to be 
able to have outcome data on more or less everyone who was treated’ (respondent 10; 
emphasis in original). Outcomes measures continue to be framed as providing epistemic 
and procedural credibility, which translates into political accountability. Without them, 
as respondent 10 told me, ‘I don’t think [IAPT] would have continued political support’. 
Despite clinical and normative claims about the import of outcome measures in IAPT, it 
is the economic and (consequently) political accountabilities relating to these that leaders 
of the initiative have often portrayed as particularly significant.
Given the salience of outcomes monitoring to IAPT – and their subsequent promotion 
by initiative leaders and other key healthcare figures and institutions – it is worth noting 
that this practice was not introduced by the programme. Rather, monitoring and evalua-
tion have been advocated since at least the 1990s (e.g. Department of Health, 1999; see 
also Roth and Fonagy, 1996). This has often been on the grounds of (political pushes 
towards) clinical accountability (e.g. Margison et al., 2000; National Institute for Mental 
Health in England (NIMHE), 2008), generating tension and conflict within therapy com-
munities (Power, 1999). IAPT was thus constituted within a landscape where measure-
ment was already encouraged. Nonetheless, a 2012 NHS report lamented that when 
‘outcomes data is available, the variety of indicators used do not allow for effective 
benchmarking and comparison’ (NHS Confederation, 2012: 82). Today, calculating out-
comes is more forcefully mandated by policymakers, and is key to service commission-
ing and provider reimbursement (so-called ‘payment by results’) in an increasingly 
privatized NHS (e.g. Department of Health, 2013). My interviews with mental health 
professionals in non-IAPT settings indicated that routine, systematic, and standardized 
outcomes measurements have only relatively recently become common.13 I was even 
sometimes told (e.g. by one key civil servant associated with IAPT, as well as by various 
psychologists) that patients ‘like’ outcome measures. Hence, outcome measures do not 
just ensure that the direction of accountability travels ‘up’ to service and IAPT leaders, 
and ultimately policymakers and politicians, but also ‘down’ to patients themselves. 
Given policy emphases on patient choice (Greener, 2009), augmenting accountability to 
service users also enhances its political legitimacy.
The implications of IAPT for mental healthcare do not, then, lie in the introduction of 
outcomes monitoring as a completely novel notion. Rather, the ramifications of the 
English IAPT initiative can be seen in how it has contributed to establishing data collec-
tion in a range of mental health services across the UK as a necessary and ever-more 
routine practical task for clinicians and services in order to demonstrate clinical and 
economic accountability. Consequently, though generally presented by IAPT leaders as 
appropriately responsive to the demands of technocratic governance (Porter, 1995), 
claims about the collection and evaluation of patient outcomes have also contributed to 
the consolidation of this authority.
Discussion
A decade after its launch, the reach of IAPT continues to expand. Its operations are held 
up as examples from which other NHS services might learn, and policymakers and clini-
cians beyond the UK have expressed interest in embedding similar models within their 
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own health systems. Australia, for instance, has self-consciously followed the lessons of 
IAPT (Cromarty et al., 2016). In England and the wider UK, many researchers, clini-
cians, and patients have praised it for helping to make the NHS accountable to scientific 
evidence and human need. Layard and Clark (2014) followed up the 2006 ‘Depression 
Report’ with a book for a general readership, Thrive, in which IAPT was presented as a 
‘great humanitarian project’ (p. 207) and ‘has shown that it is possible in a short time to 
make big improvements in the lives of hundreds of thousands of people’ (p. 201). Perhaps 
unsurprisingly, in light of their earlier messaging, Layard and Clark (2014) described 
access to therapy as simultaneously ‘morally right’ and ‘vital for our economy’ (p. ix).
Still, as Barry (2002) notes, ‘the organization of any regime is always open to the 
possibility of contestation’ (p. 275). And criticisms of IAPT have been plentiful. 
Mental health professionals – including IAPT therapists and managers themselves – 
commonly express disquiet about the programme: to me directly in interviews and 
casual conversations, and across the academic and professional literature, blogs, and 
social media (see also Marks, 2012). Concerns relate to the widespread use of CBT 
(and its elite metropolitan advocates), challenges to therapeutic quality that might 
result from prioritizing particular kinds of outcomes measures, and how economic 
rationales impinge upon – and change the nature of – clinical care. Even some of the 
key health economic claims made about psychological therapy have been contested 
(McCrone, 2013), and antidepressant prescriptions continue to rise (Health and Social 
Care Information Centre, 2016).
When IAPT is criticized, its advocates frame the various choices made during the 
development of the initiative as almost inevitable. Justifications relate to the accountabil-
ities that Clark, Layard, and colleagues have emphasized through the initiative, and the 
measures and means chosen to demonstrate it. The accountabilities constitutive of IAPT 
were, chiefly, economic, epistemic, and clinical. They were built into the operations of 
the programme in ways that enabled its advocates to present it as reasonable and rational, 
and hence any naysayers as uninformed, misguided, or even self-interested (e.g. Fonagy 
and Clark, 2015). Their integration with the programme has served as a robust shield 
with which to deflect critique. The decisions made by IAPT leaders when responding to 
the broader healthcare landscape during the development phase of the initiative have 
come, to a significant extent, to be reified as not merely a way of developing public 
mental health, but as the (only) way. Elegantly advanced justifications for and defenses 
of IAPT align closely and resonate with a seemingly ever-more economistic framing of 
the public good by the UK Government, further closing down spaces within which the 
problematizations that might propel alternative therapeutic futures can be developed. 
This discourse of inevitability (Massey, 1999: 7) has helped to authorize and legitimate 
the decisions of the early IAPT proponents and leaders, and consequently the situation of 
the initiative has itself morphed. From being but one feature of a wider public health 
ecosystem with roots in some existing practices, IAPT has reshaped its environment and 
is now a principal entity to which other practitioners and services must respond (cf. 
MacKenzie, 2015; MacKenzie and Pardo-Guerra, 2014). It is in this sense that the initia-
tive has moved from ‘content to context’ (MacKenzie, 2015).
Such ‘contextification’ has been highly reliant on an economic problematization 
of ill-health. Today, the problematization emphasizes a certain kind of psychological 
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ontology for subjective distress, the operationalizing of this in categorical terms (e.g. 
depression, anxiety), the possibility of swiftly quantifying such constructs in terms of 
severity, the necessity of standardized and readily applicable forms of therapy, and the 
significance of diversely trained clinicians with varying degrees of psychological exper-
tise. This economic problematization also foregrounds the vital role of measurement in 
simultaneously evidencing clinical need, therapeutic efficacy, and prudent expenditure. 
These features are exemplified by IAPT, and while not wholly reducible to the initiative 
have nevertheless become ever more characteristic of other mental healthcare settings. 
This is in part due to the lauding that IAPT has widely received and its casting as an 
exemplar programme by bodies such as NICE (the influence of which itself has grown 
with and through the initiative).
The psychological is commonly counterpoised with the biomedical in the more 
polemical tropes of some mental health professionals. We might reasonably speculate 
whether the rise of IAPT represents a reconstitution of psychology through biomedical 
ways of knowing and acting upon distress – or, in contrast, a kind of dissolution of the 
significance of biomedicine within mental health. However, the instantiation of IAPT is 
neither a straightforward case-study of biomedicalization (Clarke et al., 2003) nor an 
example of an initiative that has evolved as direct challenge to it. IAPT has developed its 
character in virtue of its constitution through economic expertise that at least purports to 
be agnostic about the quintessence of pathology, and styles its machinations through a 
kind of reflexive ontological neutrality. Depending on how IAPT catches any analytic 
light shed upon it, either psychological or biomedical facets can reflect back – or both 
can. Indeed, the existence of IAPT further complicates the possibility of drawing sharp 
lines between these domains. Notwithstanding the wider utility of theories of biomedi-
calization, then, the rise of IAPT seems to signal that there is more to contemporary 
healthcare than analyses that are restricted to situating developments along this concep-
tual axis might imply.
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Notes
 1. IAPT is an English, rather than a British, initiative, given the devolution of healthcare provi-
sion to the constituent nations constituting the UK. The logics associated with the initiative 
are pervasive beyond England, however.
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 2. As part of the increasingly complex interplay between the public and private sectors 
within England, service providers now also include organizations such as Virgin Care 
(part of the multinational Virgin Group) and charities such as Mind, often partnering with 
the NHS.
 3. For the first interview phase, eleven semi-structured interviews (and one shorter, recorded 
conversion) were conducted, lasting between 30 minutes and two hours. One interview 
focussed explicitly on Scottish, rather than English, policy; however, comparisons between 
the two nations formed part of the discussion. A further 40 interviews with clinical psycholo-
gists in England and Scotland, and five focus groups with psychologists and advocacy organi-
zations generated additional data. Further context is provided by very many conversations 
with clinicians, service-users, and activists, some of which were facilitated through public 
engagement events I organized or participated in. Interviews and focus groups were con-
ducted between 2012 and 2015, with discussions with mental health professionals, service-
users, activists, and others around issues of access to psychological therapy in primary care 
settings beginning in 2010 (and continuing to the present day).
 4. For relevant work in history and STS, see Buchanan (1997), Danziger (1990), Derksen (2001), 
Hayward (2014), Kusch (1999), Morawski (1988), Rose (1996), and Thomson (2006).
 5. Others have examined the biomedical (re)construction and treatment of psychopathology 
(Healy, 2004; Horwitz and Wakefield, 2007; Kitanaka, 2011; Lee, 1999; Luhrmann, 2000; 
Rose, 2007; Rosenberg, 2006), though have largely refrained from emphasising explicitly 
psychological modalities of care.
 6. Clark is not cited in the report, nor listed in the acknowledgements. Rather, Baroness Molly 
Meacher (Layard’s wife and Chair of the East London and City Mental Health Trust) was 
noted as ‘a virtual co-author of the paper’ (Layard, 2005a: 25).
 7. ‘The Depression Report’ was advertised in the 3rd September 2006 edition of The Observer, 
via support from the Charlie Waller Memorial Trust.
 8. ‘We Need to Talk’ was commissioned by five major mental health charities: The Mental Health 
Foundation, Mind, Rethink, The Sainsbury Centre for Mental Health, and Young Minds. It 
was published one month after ‘The Depression Report’. For coverage, see Frauenfelder 
(2006).
 9. The New Savoy Partnership included Pam Maras (then President of the British Psychological 
Association), Peter Fonagy (Chief Executive of the prestigious Anna Freud Centre), and Paul 
Farmer (Chief Executive of the leading mental health charity Mind).
10. Doncaster focussed on depression, with Newham dealing with depression and anxiety dis-
orders. Newham was part of the geographic area covered by the East London and City 
Mental Health Trust, chaired by Baroness Molly Meacher – Layard’s wife, a key influ-
ence on the Layard (2005a) ‘Mental Health’ report, and a co-signatory of ‘The Depression 
Report’.
11. Until 2016, NICE guidelines for mental health conditions were produced by the National 
Collaborating Centre for Mental Health (Kendall et al., 2004).
12. An evaluation funded by the Department of Health through its National Institute of Health 
Research, however, raised several caveats about the initiative, not least of which related to its 
very swift development and implementation (see Rick et al., 2010).
13. The ‘CORE’ framework (Evans et al., 2000, 2002) was often highlighted as a useful mecha-
nism for outcomes measurement.
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